News

Release Date Release Title
06-01-2017 Therapeutic Solutions International Announces Exclusive Patent License Agreement with Subsidiary Emvolio, Inc.
05-18-2017 Therapeutic Solutions International Announces Exclusive Patent License Agreement to innaMune with its Subsidiary Emvolio, Inc.
05-10-2017 Therapeutic Solutions International Announces Exclusive Patent License Agreement with its Subsidiary Emvolio, Inc.
05-01-2017 Therapeutic Solutions International Announces Appointment of Dr. Thomas E. Ichim to its Subsidiary Emvolio, Inc.
04-12-2017 Therapeutic Solutions International’s Subsidiary, Emvolio, Inc., Files Investigational New Drug Application for StemVacs Cancer Immunotherapy
04-10-2017 Therapeutic Solutions International Announces Filing of new Immunotherapy Patent and Exclusive Patent License Agreement with Subsidiary Emvolio, Inc.